BSA
HALO icon

Braun Stacey Associates’s Halozyme HALO Stock Holding History

Braun Stacey Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,998
Closed -$649K – 128
2023
Q1 		$649K Sell
16,998
-334,021
-95% -$15.7M 0.02% 121
2022
Q4 		$20M Buy
351,019
+93,897
+37% +$4.81M 1.14% 31
2022
Q3 		$10.2M Buy
+257,122
New +$11.4M 0.62% 80

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Braun Stacey Associates's HALO Position: Q2 2023 in Review

Braun Stacey Associates sold out of Halozyme (HALO) in Q2 2023, closing a stake of 16,998 shares — an estimated $649K sold.

Braun Stacey Associates first reported a position in HALO in Q3 2022 and held it in 3 quarters. The position peaked at $20M in Q4 2022. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.

  • Braun Stacey Associates reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
  • Braun Stacey Associates sold 16,998 Halozyme shares in Q2 2023, an estimated $649K.
  • Braun Stacey Associates first reported a position in Halozyme in Q3 2022 and held it in 3 quarters.
  • Braun Stacey Associates's Halozyme position peaked at $20M in Q4 2022.
  • 370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.

Based on Braun Stacey Associates's 13F filing for Q2 2023, filed 28 Jul 2023.